SS Innovations International, Inc. (SSII)
Nasdaq · Healthcare · Medical Devices
$2.77+3.75%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $555M
- 52-week range
- $2.62 – $10.00
- 52-week change
- −60.74%
- EPS (trailing)
- −$0.06
- Next earnings
- Oct 27, 2026
Fiscal year to Dec 2025
- Revenue
- $42.5M (+105.74%)
- Net income
- −$12.1M
- Operating margin
- −19.3%
- Diluted EPS
- −$0.06
- Free cash flow
- −$22.2M
From the company’s annual report on SEC EDGAR.
About SS Innovations International, Inc.
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device.
Headquarters: Gurugram, India · 483 employees · ssinnovations.com